Journal article
Authors list: Taghizadeh, Sara; Chao, Cho-Ming; Guenther, Stefan; Glaser, Lea; Gersmann, Luisa; Michel, Gabriela; Kraut, Simone; Goth, Kerstin; Koepke, Janine; Heiner, Monika; Vazquez-Armendariz, Ana Ivonne; Herold, Susanne; Samakovlis, Christos; Weissmann, Norbert; Ricci, Francesca; Aquila, Giorgio; Boyer, Laurent; Ehrhardt, Harald; Minoo, Parviz; Bellusci, Saverio; Rivetti, Stefano
Publication year: 2022
Pages: 605-617
Journal: Stem Cells
Volume number: 40
Issue number: 6
ISSN: 1066-5099
eISSN: 1549-4918
Open access status: Hybrid
DOI Link: https://doi.org/10.1093/stmcls/sxac025
Publisher: Oxford University Press
Abstract:
Bronchopulmonary dysplasia (BPD) is a neonatal lung disease developing in premature babies characterized by arrested alveologenesis and associated with decreased Fibroblast growth factor 10 (FGF10) expression. One-week hyperoxia (HYX) exposure of newborn mice leads to a permanent arrest in alveologenesis. To test the role of Fgf10 signaling to promote de novo alveologenesis following hyperoxia, we used transgenic mice allowing inducible expression of Fgf10 and recombinant FGF10 (rFGF10) protein delivered intraperitoneally. We carried out morphometry analysis, and IF on day 45. Alveolospheres assays were performed co-culturing AT2s from normoxia (NOX) with FACS-isolated Sca1(Pos) resident mesenchymal cells (rMC) from animals exposed to NOX, HYX-PBS, or HYX-FGF10. scRNAseq between rMC-Sca1(Pos) isolated from NOX and HYX-PBS was also carried out. Transgenic overexpression of Fgf10 and rFGF10 administration rescued the alveologenesis defects following HYX. Alveolosphere assays indicate that the activity of rMC-Sca1(Pos) is negatively impacted by HYX and partially rescued by rFGF10 treatment. Analysis by IF demonstrates a significant impact of rFGF10 on the activity of resident mesenchymal cells. scRNAseq results identified clusters expressing Fgf10, Fgf7, Pdgfra, and Axin2, which could represent the rMC niche cells for the AT2 stem cells. In conclusion, we demonstrate that rFGF10 administration is able to induce de novo alveologenesis in a BPD mouse model and identified subpopulations of rMC-Sca1(Pos) niche cells potentially representing its cellular target.
Citation Styles
Harvard Citation style: Taghizadeh, S., Chao, C., Guenther, S., Glaser, L., Gersmann, L., Michel, G., et al. (2022) FGF10 Triggers de novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells, Stem Cells, 40(6), pp. 605-617. https://doi.org/10.1093/stmcls/sxac025
APA Citation style: Taghizadeh, S., Chao, C., Guenther, S., Glaser, L., Gersmann, L., Michel, G., Kraut, S., Goth, K., Koepke, J., Heiner, M., Vazquez-Armendariz, A., Herold, S., Samakovlis, C., Weissmann, N., Ricci, F., Aquila, G., Boyer, L., Ehrhardt, H., Minoo, P., ...Rivetti, S. (2022). FGF10 Triggers de novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells. Stem Cells. 40(6), 605-617. https://doi.org/10.1093/stmcls/sxac025
Keywords
alveologenesis; BRANCHING MORPHOGENESIS; FGF-10; GROWTH-FACTOR 10; MOUSE LUNG; rFGF10; rMC-Sca1(Pos); scRNASeq